Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 pilot study of reparixin to prevent delayed graft function after kidney transplantation
2005-001300-39Phase 2Completed
- Sponsor
- Dompé
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of reparixin in delayed graft function (DGF) (3 arms), sponsored by Dompé. Primary endpoint: Primary efficacy endpoint. Started Jun 2005; status: completed.
02
Drugs
reparixin
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on 2005-001300-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001300-39.